Dr. Ivan Balla

• Operational and scientific lead of a large (3500 patients, 400 centres, 15 countries) international observational study with Tysabri in Relapsing-Remitting Multiple Sclerosis (RRMS), in close collaboration with CRO’s and affiliates.

• Responsible for all operational aspects of global clinical studies, from study start-up to study closure, in close collaboration with the affiliates and vendors. • Operational lead of a large prospective post-approval commitment study with 2800 patients suffering from chronic kidney disease, comprising more than 150 centers in 23 countries (including Asia-Pacific and Latin America).

• Managed, coordinated and supervised large international phase IIIb and IV studies in Multiple Sclerosis, in close collaboration with crossfunctional teams, Contract Research Organizations and affiliates / distributors worldwide. • As project leader managed successfully the “global adherence project”, a retrospective observational study with Avonex in RRMS, conducted in 22 countries. • Managed all departments’ contracting, budgeting and finance issues, and ensured successful project's deliverables

• Organized the “1st, 2nd and 3rd Day of Clinical Research” at the faculty of medicine, an important scientific exchange platform between the numerous research groups. • Established and maintained an adequate website, informing the target audience concisely about faculty’s scientific competencies.

• Planned, co-ordinated, managed and supervised multinational phase II and III clinical trials on safety and efficacy of Epoetin alfa in patients suffering from cancer or chronic renal failure. • Established extensive information channels and productive business relationships with different teams in Switzerland and the US, as well as with the international operating companies worldwide. Thereby ensured smooth study conduct and high data quality, in compliance with given time frames.

• Guided a team of 8 information specialists, supervised and optimised all team’s activities • Assessed the scientific information needs of the worldwide clientele and ensured successful business activities through delivery of high quality information services. • Provided competent and prompt support to internal departments as well as to international operating companies worldwide with broad range of information services on pharmaceutical and clinical research and development.

• Organized, coordinated and monitored phase II and III international clinical trials. Built up a mutual trust with the investigators and ensured timely delivery of high quality data.

• Independently organised, conducted, analysed and reported pre-clinical studies dealing with combined effects of ionising radiation and various agents (cytostatic drugs, heavy metals) on the prenatal development in rodents. Successfully published the study results in form of sixteen articles and presentations at scientific symposia and congresses.

Zoologie